Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells

Abstract

Transcriptional silencing by CpG island methylation is a prevalent mechanism of tumor-suppressor gene suppression in cancers1,2,3,4. Genetic experiments have defined the importance of the DNA methyltransferase Dnmt1 for the maintenance of methylation in mouse cells5 and its role in neoplasia6. In human bladder cancer cells, selective depletion of DNMT1 with antisense inhibitors has been shown to induce demethylation and reactivation of the silenced tumor-suppressor gene CDKN2A7. In contrast, targeted disruption of DNMT1 alleles in HCT116 human colon cancer cells produced clones that retained CpG island methylation and associated tumor-suppressor gene silencing8, whereas HCT116 clones with inactivation of both DNMT1 and DNMT3B showed much lower levels of DNA methylation, suggesting that the two enzymes are highly cooperative9. We used a combination of genetic (antisense and siRNA) and pharmacologic (5-aza-2′-deoxycytidine) inhibitors of DNA methyl transferases to study the contribution of the DNMT isotypes to cancer-cell methylation. Selective depletion of DNMT1 using either antisense or siRNA resulted in lower cellular maintenance methyltransferase activity, global and gene-specific demethylation and re-expression of tumor-suppressor genes in human cancer cells. Specific depletion of DNMT1 but not DNMT3A or DNMT3B markedly potentiated the ability of 5-aza-2′-deoxycytidine to reactivate silenced tumor-suppressor genes, indicating that inhibition of DNMT1 function is the principal means by which 5-aza-2′-deoxycytidine reactivates genes. These results indicate that DNMT1 is necessary and sufficient to maintain global methylation and aberrant CpG island methylation in human cancer cells.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: DNMT-specific inhibitors.
Figure 2: Maintenance and de novo DNA methyltransferase (mtase) activity in DNMT1-depleted HCT116 cells.
Figure 3: Gene-specific and global demethylation induced by depletion of DNMT1 in HCT116 and SW48 cells.
Figure 4: Reactivation of silenced genes by depletion of DNMT1.

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Jones, P.A. & Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415–428 (2002).

    Article  CAS  PubMed  Google Scholar 

  2. Esteller, M. & Herman, J.G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol. 196, 1–7 (2002).

    Article  CAS  PubMed  Google Scholar 

  3. Rountree, M.R., Bachman, K.E., Herman, J.G. & Baylin, S.B. DNA methylation, chromatin inheritance, and cancer. Oncogene 20, 3156–3165 (2001).

    Article  CAS  PubMed  Google Scholar 

  4. Robertson, K.D. DNA methylation, methyltransferases, and cancer. Oncogene 20, 3139–3155 (2001).

    Article  CAS  PubMed  Google Scholar 

  5. Li, E., Bestor, T.H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915–926 (1992).

    Article  CAS  PubMed  Google Scholar 

  6. Laird, P.W. et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197–205 (1995).

    Article  CAS  PubMed  Google Scholar 

  7. Fournel, M., Sapieha, P., Beaulieu, N., Besterman, J.M. & MacLeod, A.R. Downregulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16(ink4A) and p21(WAF/Cip1) by distinct mechanisms. J. Biol. Chem. 274, 24250–24256 (1999).

    Article  CAS  PubMed  Google Scholar 

  8. Rhee, I. et al. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404, 1003–1007 (2000).

    Article  CAS  PubMed  Google Scholar 

  9. Rhee, I. et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552–556 (2002).

    Article  CAS  PubMed  Google Scholar 

  10. Beaulieu, N. et al. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J. Biol. Chem. 277, 28176–28181 (2002).

    Article  CAS  PubMed  Google Scholar 

  11. Okano, M., Bell, D.W., Haber, D.A. & Li, E. DNA methyltransferases DNMT3a and DNMT3b are essential for de novo methylation and mammalian development. Cell 99, 247–257 (1999).

    Article  CAS  PubMed  Google Scholar 

  12. Li, E., Beard, C. & Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature 366, 362–365 (1993).

    Article  CAS  PubMed  Google Scholar 

  13. Yoder, J.A., Soman, N.S., Verdine, G.L. & Bestor, T.H. DNA (cytosine-5)- methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. J. Mol. Biol. 270, 385–395 (1997).

    Article  CAS  PubMed  Google Scholar 

  14. Gonzalez-Zulueta, M. et al. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55, 4531–4535 (1995).

    CAS  PubMed  Google Scholar 

  15. Merlo, A. et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1, 633–634 (1995).

    Article  Google Scholar 

  16. Myohanen, S.K., Baylin, S.B. & Herman, J.G. Hypermethylation can selectively silence individual CDKN2A alleles in neoplasia. Cancer Res. 58, 591–593 (1998).

    CAS  PubMed  Google Scholar 

  17. Herman, J.G. et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA 95, 6870–6875 (1999).

    Article  Google Scholar 

  18. Kane, M.F. et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair–defective human tumor cell lines. Cancer Res. 57, 808–811 (1997).

    CAS  PubMed  Google Scholar 

  19. Leung, S.Y. et al. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res. 59, 159–164 (1999).

    CAS  PubMed  Google Scholar 

  20. Pogribny, I., Yi, P. & James, S.J. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochem. Biophys. Res. Commun. 262, 624–628 (1999).

    Article  CAS  PubMed  Google Scholar 

  21. Jutterman, R., Li, E. & Jaenisch, R. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl. Acad. Sci. USA 981, 11797 (1994).

  22. Christman, J.K., Schneiderman, N. & Acs, G. Formation of highly stable complexes between 5-azacytosine-substituted DNA and specific non-histone nuclear proteins. Implications for 5-azacytidine-mediated effects on DNA methylation and gene expression. J. Biol. Chem. 260, 4059–4068 (1985).

    CAS  PubMed  Google Scholar 

  23. Haaf, T. & Schmid, M. 5′-Azadeoxycytidine-induced undercondensation in the giant X chromosomes of Microtus agrestis. Chromosoma 98, 93–98 (1989).

    Article  CAS  PubMed  Google Scholar 

  24. Haaf, T. The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: implications for methylation-associated cellular processes. Pharmacol. Ther. 65, 19–46 (1995).

    Article  CAS  PubMed  Google Scholar 

  25. Liang, G. et al. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell Biol. 22, 480–491 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Jonkers, J. & Berns, A. Conditional mouse models of sporadic cancer. Nat. Rev. Cancer 2, 251–265 (2002).

    Article  CAS  PubMed  Google Scholar 

  27. Bachman, K.E., Rountree, M.R. & Baylin, S.B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 276, 32282–32287 (2001).

    Article  CAS  PubMed  Google Scholar 

  28. Margot, J.B., Cardoso, M.C. & Leonhardt, H. Mammalian DNA methyltransferases show different subnuclear distributions. J. Cell. Biochem. 83, 373–379 (2001).

    Article  CAS  PubMed  Google Scholar 

  29. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821–9826 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Agathanggelou, A. et al. Methylation-associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 20, 1509–1518 (2001).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Robert MacLeod.

Ethics declarations

Competing interests

All authors are employees of MethylGene, a privately owned biotechnology company. MethylGene does not have company stock, but employees have company-issued options to purchase MethylGene shares.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robert, MF., Morin, S., Beaulieu, N. et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33, 61–65 (2003). https://doi.org/10.1038/ng1068

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng1068

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing